Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results - Publikation - Autoren - KSSG Forschungsdatenbank

Publikation

Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results

Wissenschaftlicher Artikel/Review - 01.08.2003

Nabholtz J M, Bonneterre J, Buzdar A, Robertson J F R, Thürlimann Beat

Nabholtz, J M

Bonneterre, J

Buzdar, A

Robertson, J F R

Thürlimann, Beat